ALBERTI, ALFREDO
ALBERTI, ALFREDO
"IN VITRO" LYMPHOCYTE RESPONSE TO HBcAg IN CHRONIC HBV INFECTION
1985 Casini, A; Alberti, Alfredo; Milani, S; Schiavon, E; Ricci O., E; Pontisso, Patrizia; Surrenti, C; Realdi, Giuseppe
405 HCV NS5A phosphorylation by CK2 is genotype dependent
2006 F., Dal Pero; DI MAIRA, Giovanni; Marin, Oriano; G., Bortoletto; Pinna, Lorenzo; Ruzzene, Maria; Alberti, Alfredo; M., Gerotto
[Active specific anti-hepatitis B-immunoprophylaxis: I. Results in a case file of professionals exposed in a nosocomial environment].
1985 Corridori, S; Alberti, Alfredo; Trespi, G; Campisi, D; Vlacos, D; Melzi d'Eril, Gl; Renzetti, I.
[Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study].
1975 Realdi, G; Tremolada, F; Alberti, Alfredo; Rigoli, A; Diodati, G; Visconti, M.
[Humoral and cellular immunoreactions against HBsAg and liver-specific proteins in the course of acute and chronic hepatitis].
1976 Realdi, G; Alberti, Alfredo; Bortolotti, Flavia; Tremolada, F; Diodati, G; Cadrobbi, P.
[Infection due to hepatitis B virus and host immune response].
1976 Realdi, G; Bortolotti, Flavia; Alberti, Alfredo; Fattovich, G; Ongaro, G.
[Liver-specific proteins and autoimmunity in inflammatory liver diseases].
1976 Alberti, Alfredo; Realdi, G; Bortolotti, Flavia; Trevisan, A; Tremolada, F; Rigoli, A.
[Presence of HBsAg and IgG on the membrane of hepatic cells in patients with acute and chronic hepatitis].
1976 Alberti, Alfredo; Realdi, G; Tremolada, F; Rigoli, Am; Fattovich, G; Spina, Gp
[Treatment of cryptogenic chronic liver diseases with recombinant alpha-2a interferon. Preliminary results of a randomized controlled clinical trial].
1990 Bonetti, P; Diodati, G; Scaccabarozzi, S; Realdi, G; Tagger, A; Alberti, Alfredo; Ruol, A.
A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.
2001 Gerotto, M; DAL PERO, F; Loffreda, S; Bianchi, F; Alberti, Alfredo; Lenzi, M.
A 7 year survey of acute hepatitis type B.
1983 Bortolotti, Flavia; Cadrobbi, P; Bertaggia, A; Rude, L; Alberti, Alfredo; Realdi, G.
A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression
2007 Young, B; Gerotto, M; Morcolongo, M; DAL PERO, F; Lagier, R; Rowland, C; Sebastiani, G; Alberti, Alfredo; Alameda, C.
A critical appraisal of current approaches to treatment of chronic hepatitis B (CHB)based on a review by an international panel of investigators and a survey of AASLD membership
2005 Perrillo, Rp; Gish, R; Peters, M; Keeffe, E; Alto, P; Alberti, Alfredo; BUTI FERRET, M; Cooksley, Wge; Fried, Mw; Hadziyannis, S; Liaw, Yf; Naoumov, Nv; Schiff, Er; Thio, Cl; Tsai, Nc; Schlam, Sw
A model to predict long-term sustained response to interferon therapy in chronic hepatitis C
1997 Noventa, Franco; DE SALVO G., L; Chemello, Liliana; Pontisso, Patrizia; Alberti, Alfredo
A proposed system for the nomenclature of hepatitis C viral genotypes.
1994 Simmonds, P; Alberti, Alfredo; Alter, Hj; Bonino, F; Bradley, Dw; Brechot, C; Brouwer, Jt; Chan, Sw; Chayama, K; Chen, Ds
A RANDOMIZED CONTROLLED TRIAL OF LYMPHOBLASTOID INTERFERON ALPHA IN PATIENTS WITH CHRPNIC HEPATITIS B LACKING HBeAg
1992 Fattovich, G.; Farci, P.; Rugge, Massimo; Brollo, L.; Mandas, A.; Pontisso, Patrizia; Giustina, G; Lai, Me; Belussi, F; Busatto, G; Balestrieri, A; Ruol, A; Alberti, Alfredo
A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg.
1992 Fattovich, G; Farci, P; Rugge, Massimo; Brollo, L; Mandas, A; Pontisso, Patrizia; Giustina, G; Lai, Me; Belussi, F; Busatto, G; Balestrieri, A; Ruol, A; Alberti, Alfredo
A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B
1994 Fattovich, G.; Giustina, G.; Alberti, Alfredo; Guido, Maria; Pontisso, Patrizia; Favarato, S.; Benvegnu', Luisa; Ruol, A.
A scoring system to predict the risk of hepatocellular carcinoma (HCC) in patients with compensated cirrhosis.
2005 Benvegnu', Luisa; Noventa, Franco; Gios, M; Pasin, F; Alberti, Alfredo
A seven-gene signature (cirrhosis risk score) predictsliver fibrosis progression in patients with initially mild chronic hepatitis C.
2009 Marcolongo, M; Young, B; DAL PERO, F; Fattovich, G; Peraro, L; Guido, Maria; Sebastiani, G; Palu', Giorgio; Alberti, Alfredo